Comments to the Editor on “Outcomes and Costs of Risperidone versus Olanzapine in Patients with Chronic Schizophrenia or Schizoaffective Disorders- A Markov Model”
Abstract
Authors
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now